KalGene and its NRC partners have identified a novel biological agent against amyloid-beta for Alzheimer’s disease. The IRAP project will support the late-stage development of the drug candidate..
KALGENE PHARMACEUTICALS INC.
10 records totalling $1,824,000.00 CAD, from official Government of Canada open data.
Embed this chart
Lobbying registry — possible match matched by name
An organization with this name appears in 2 federal lobbying registrations (0 currently active), between 2012 and 2016.
782641-358473-1 — Magnet Strategy Group 777816-299229-1 — MoenGlobal Advisors Inc.
Matched automatically by organization name; a different organization with the same name is possible. The Registry of Lobbyists is the authoritative source. Lobbying is legal and regulated — this is context, not an allegation.
By department
| National Research Council Canada | $1,824,000 | 10 records |
Records
Kalgene Pharmaceuticals Inc.
$350,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2017-2018
Canada
KALGENE PHARMACEUTICALS INC.
$282,000.00
National Research Council Canada | Conseil national de recherches Canada
FY 2017-2018
Canada
KALGENE PHARMACEUTICALS INC.
$232,000.00
National Research Council Canada | Conseil national de recherches Canada
FY 2011-2012
Canada
KALGENE PHARMACEUTICALS INC.
$185,000.00
National Research Council Canada | Conseil national de recherches Canada
FY 2010-2011
Canada
KALGENE PHARMACEUTICALS INC.
$174,000.00
National Research Council Canada | Conseil national de recherches Canada
FY 2011-2012
Canada
KALGENE PHARMACEUTICALS INC.
$170,000.00
National Research Council Canada | Conseil national de recherches Canada
FY 2009-2010
Canada
KALGENE PHARMACEUTICALS INC.
$160,000.00
National Research Council Canada | Conseil national de recherches Canada
FY 2011-2012
Canada
KALGENE PHARMACEUTICALS INC.
$141,000.00
National Research Council Canada | Conseil national de recherches Canada
FY 2010-2011
Canada
KALGENE PHARMACEUTICALS INC.
$90,000.00
National Research Council Canada | Conseil national de recherches Canada
FY 2011-2012
Canada
KALGENE PHARMACEUTICALS INC.
$40,000.00
National Research Council Canada | Conseil national de recherches Canada
FY 2011-2012
Canada